🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Jash Dholani We started Apoha on this premise four years ago. In my view, it goes much deeper than just attributing it to the randomness of water (which I know has been simplified for the popular format of the article). Research on intelligence needs a shift from thinking of intelligence as

If you were betting $100M on things you barely control, most would call it a gambling addiction. In startups, it’s ambition. Joined by Sean Gourley of Primer

Nothing worth building takes less than 5 years. It’s years of physical, mental, and emotional endurance. While first-time founders chase milestones, second-timers build systems to stay sane. Joined by Sean Gourley, founder and former CEO of Primer

Not every raise is worth it. At a certain stage, the return on time, dilution, and stress just doesn't add up. The question of "Have you thought about selling it?" shouldn't be a taboo. Joined by Sean Gourley of Primer

Most VCs aren’t excited about a $400M exit. Most solo founders are. That’s where alignment fractures, and why solo founders get nudged out. Founders: know who you’re building for. Joined by Sean Gourley, founder and former CEO of Primer

If you’ve got nothing to lose, don’t waste it. By Sean Gourley of Primer

First ask yourself “What’s cool enough that I want to work on it every day?” And only then ask “Can I make a company from that?” Joined by Sean Gourley, founder and former CEO of Primer

who’s in Munich next Tuesday 07/15? We have a few spots open for scientists, engineers + investors interested in spending time with Francesco, co-founder and CEO Proxima Fusion on their journey from 0 to closing $150M series A in 2 years and maybe checking out what a

Last night in Cambridge! Full house, buzzing with curious minds, scientist-founders (new + seasoned), and conversations that went way past closing time. Huge thanks to everyone who came, see you again soon!

Some of the biggest scientific breakthroughs start with curiosity, not KPIs. But social impact still matters. And the Innovative Genomics Institute (IGI) is doing both. Joined by Brad Ringeisen, Executive Director at IGI.

A model that blends VC mindset with philanthropic intention is emerging – early bets on risky research, backed by investors and mission-driven capital. It’s not charity. It’s a long view on innovation. By Brad Ringeisen, Executive Director of the Innovative Genomics Institute

the best scientists often leave for these reasons - if you're exploring life beyond academia, check out Wilbe